2021-01-03,b'How to I Find Stocks to Trade Every Day?  (Using Scanners to Pick Penny Stocks)\n\nhttps://t.co/bJ77gvVoWk\n\n$BNSO $ACY $BNGO $AINC $BTBT $HOTH $IPI $WBAI $CDAK $LUMO $PFIN $CVU'
2021-01-03,b'MY SIMPLE SWING TRADING STRATEGY TO LOCK IN CONSISTENT GAINS\n\nhttps://t.co/IQUIOGXQGe\n\n$BNSO $ACY $BNGO $AINC $BTBT $HOTH $IPI $WBAI $CDAK $LUMO $PFIN $CVU'
2021-01-03,b'How to Become Financially Free (Four Steps You Need to Know)\n\nhttps://t.co/hA8kcCWDIG\n\n$BNSO $ACY $BNGO $AINC $BTBT $HOTH $IPI $WBAI $CDAK $LUMO $PFIN $CVU'
2021-01-02,b'HOW TO CALCULATE RSI IN GOOGLE SHEETS (Also works in EXCEL)\n\nhttps://t.co/IBVy7JVnlM\n\n$BNSO $ACY $BNGO $AINC $BTBT $HOTH $IPI $WBAI $CDAK $LUMO $PFIN $CVU'
2021-01-02,"b""With #Bitcoin breaking all time highs, here's how to Buy BITCOIN on Robinhood (Step-by-Step Tutorial for Beginners)\n\nhttps://t.co/9nIdDs0IiB\n\n$BNSO $ACY $BNGO $AINC $BTBT $HOTH $IPI $WBAI $CDAK $MARA $PFIN $CVU $BTC"""
2021-01-02,b'5 Pitfalls of New Traders and How to Avoid Them!\n\nhttps://t.co/wTb8jUh2kO\n\n$BNSO $ACY $BNGO $AINC $BTBT $HOTH $IPI $WBAI $CDAK $LUMO $PFIN $CVU'
2021-01-02,b'Why Do Most Traders Fail? A Must-Know for Beginners!  \n\nhttps://t.co/gz7du9sOMs  \n\n$BNSO $ACY $BNGO $AINC $BTBT $HOTH $IPI $WBAI $CDAK $LUMO $PFIN $CVU'
2021-01-02,b'RT @keithmcmxc: $CDAK ended the year so well by reaching the $32 mark. I am happy.'
2021-01-02,b'RT @keithmcmxc: $CDAK ended the year so well by reaching the $32 mark. I am happy.'
2021-01-02,b'$CDAK ended the year so well by reaching the $32 mark. I am happy.'
2021-01-01,b'RT @stocktraderjack: Which Broker Should I use?\n\nhttps://t.co/HdPHCYHI9E\n\n$BNSO $ACY $BNGO $AINC $BTBT $HOTH $IPI $WBAI $CDAK $LUMO $PFIN $\xe2\x80\xa6'
2021-01-01,b'Which Broker Should I use?\n\nhttps://t.co/HdPHCYHI9E\n\n$BNSO $ACY $BNGO $AINC $BTBT $HOTH $IPI $WBAI $CDAK $LUMO $PFIN $CVU'
2021-01-01,b'RT @ProfitTradeRoom: +326.2% total profit realized in November (check fleet) \xf0\x9f\x93\x84\n\n$CAAS runner of the day! \xf0\x9f\x9a\x80\n\nGreat start of the new week\nGre\xe2\x80\xa6'
2021-01-01,b'RT @ProfitTradeRoom: +326.2% total profit realized in November (check fleet) \xf0\x9f\x93\x84\n\n$CAAS runner of the day! \xf0\x9f\x9a\x80\n\nGreat start of the new week\nGre\xe2\x80\xa6'
2021-01-01,b'RT @HighHeeledTradr: Support: What It Means and How to Make Money Using It\n\nhttps://t.co/RYH4qN9kcf\n\n$BNSO $ACY $BNGO $AINC $BTBT $HOTH $IP\xe2\x80\xa6'
2021-01-01,b'Support: What It Means and How to Make Money Using It\n\nhttps://t.co/RYH4qN9kcf\n\n$BNSO $ACY $BNGO $AINC $BTBT $HOTH $IPI $WBAI $CDAK $LUMO $PFIN $CVU'
2021-01-01,"b'Stocks in New High today: $CDAK, Current Price: $32.28, Change today: 15.36%, Total Traded Volume: 295,840 https://t.co/8A3etAHddg'"
2021-01-01,b'RT @thebubbleboard: Thu Dec 31\nGaining #stocks today:\n\n$BNGO: +46.7%\n$BTBT: +44.6%\n$IPI: +36.1%\n$SGTX: +28.6%\n$LC: +26.2%\n$EBON: +23.4%\n$GC\xe2\x80\xa6'
2021-01-01,b'Thu Dec 31\nGaining #stocks today:\n\n$BNGO: +46.7%\n$BTBT: +44.6%\n$IPI: +36.1%\n$SGTX: +28.6%\n$LC: +26.2%\n$EBON: +23.4%\n$GCI: +15.9%\n$CDAK: +15.4%\n$CELH: +13.3%\n\nclick here for a visual version:\nhttps://t.co/hlYcQyQdd0 https://t.co/EWDjgotuHX'
2021-01-01,"b'RT @Sir_Wingfield: Very proud of my $CDAK call!\n\nAlerted for target $30 below 12, picked some up and let it rip! Great win team @WingTrades\xe2\x80\xa6'"
2021-01-01,b'$CDAK 24 to 32. Maybe one more white soldier to 35 before it tops out? https://t.co/cgq6qkLjEj https://t.co/nU1OpAz6OM'
2020-12-31,"b'$CDAK going to round the bases on this one.  Not only did it hit my PT yesterday, but ripped past that today. My other biotechs. $SURF $ABUS $ONCT $EARS $ITRM $SENS $AGEN https://t.co/yA7TXVYcgL'"
2020-12-31,"b'Very proud of my $CDAK call!\n\nAlerted for target $30 below 12, picked some up and let it rip! Great win team @WingTrades! \n\n#trading #swing #profits #gains #options https://t.co/ORsKSkFGMJ'"
2020-12-31,b'The old #trades vs my new #swings! Thank you all that joined @WingTrades \n\n$CDAK for 153%\n$CTRM for 180%\n$BNGO for 323% *so far https://t.co/TLgfbulaEL'
2020-12-31,b'$CDAK just doin its thing...'
2020-12-31,b'$CDAK 153%\n $CTRM 180%\n $BNGO 323%\n \n How are your swings going? https://t.co/pd07NvIeKM'
2020-12-31,"b'Stocks in New High today: $CDAK, Current Price: $29.98, Change today: 8.57%, Total Traded Volume: 69,169 https://t.co/IRzq3YY9ir'"
2020-12-31,b'Great win on $CDAK from $11.87 into target $30 beyond alltime highs \xf0\x9f\x98\x89 thank you those who joined and trusted my analysis https://t.co/NoAdSQJ5A3'
2020-12-31,b'$CDAK reaching $30 mark! That is a how you end the year with a bang! 153% return!'
2020-12-31,b'09:42 New 52wk Highs: $CDAK $ELF $LSCC $WBAI'
2020-12-31,b'Codiak price target raised to $31 from $19 at Wedbush\n$CDAK'
2020-12-31,"b'$CDAK technical alerts: New 52 Week High, Expansion Breakout, Pocket Pivot, Wide Range Bar, Upper... https://t.co/UbNd8TGYPr'"
2020-12-31,b'#Codiak Reports Positive Initial Phase 1 Results for #exoIL12\xe2\x84\xa2 Demonstrating Tolerability and Absence of Systemic #IL12 Exposure in #HealthyVolunteers $CDAK https://t.co/XKFbLwy13n'
2020-12-31,b'You can copy this $CDAK breakout chart ($24-$28 intra day) if you want to win the prize lol .. I do it on daily basis .. my bread and butter! https://t.co/EUbADWzEww'
2020-12-31,b'$cdak already 2x mooning right now \n$capr is same exosome company why capr dont go up!!'
2020-12-31,"b'RT @Bernard22190947: Dr Strange Portfolio:\n$INFN-Latency \n$ONTO-semisweet\n$SQM-Lithium, Cachai?\n$TRQ-Copper for all those EVs\n$DNLI-Alzheim\xe2\x80\xa6'"
2020-12-31,"b'RT @codiakbio: Today we reported positive initial Ph1 results for our engineered #exosome therapeutic candidate exoIL-12, demonstrating tol\xe2\x80\xa6'"
2020-12-30,b'BioPharmCatalyst updates 12/30/20:\n\n$AZN U.K. COVID-19 vaccine approval\n$KALV +21% (data 1Q 21)\n$SBTX analyst initiations (Tue) +14%\n\n$NOVN +50%; $AZRX +33%\n$OSMT -20%; $CYCC -13%\n\nPipeline updates $ALT $CDAK $PLX\n\nhttps://t.co/HU1TX3dr9X'
2020-12-30,b'Scan results - Expansion Breakout today: $NETE $DMTK $BIDU $BCOR $SSSS $OR $BILI $FCX $SILV $JELD $ACI $EAF $CDAK $VCEL $MXL $DIS $DAR $VIPS $EIGR $ALRM ... https://t.co/VUC0gR1lbE'
2020-12-30,"b'The only other EEV play on any worldwide exchange $CDAK up 29% on Phase 1 success of, ""exoIL-12: the first engineered exosome therapeutic candidate to be evaluated in humans.""\n\n#EX1 $EX1 on our little #ASX will have its day https://t.co/H7ZNDwczDE'"
2020-12-30,b'I guess chasing wasn\xe2\x80\x99t so bad after all!  $CDAK #Winning alerts heading into 2021... https://t.co/UD5pjfdSsL'
2020-12-30,"b'\xf0\x9f\x94\x8e Trending Stocks : $CDAK Codiak BioSciences Inc #TrendingStocks December 30, 2020 07:00:00 am https://t.co/3MDKRJsCMd'"
2020-12-30,b'$CDAK is rallying at closing price of $28!'
2020-12-30,b'Breaking News: $CDAK Codiak Reports Positive Initial Phase 1 Results for exoIL-12(TM) Demonstrating Tolerability and Absence of Systemic IL-12 Exposure in Healthy Volunteers https://t.co/KyHg5nzm6b\n    \n#SoreLoser @MarketChmln @YuZhu4 @AsuseMenuna $BNGO $SGOC $IPDN'
2020-12-30,"b""Dr Strange Portfolio:\n$INFN-Latency \n$ONTO-semisweet\n$SQM-Lithium, Cachai?\n$TRQ-Copper for all those EVs\n$DNLI-Alzheimers if BIIB goes down in flames\n$CDAK-Exosomes for what ails you\n$ANVS-Alzheimer lottery ticket\n$FREQ-Loss of hearing. TAM-everybody\n$SSPK-Cannibus's Quantumscape"""
2020-12-30,"b""RT @shaklakhani: Exciting early stage results from $CDAK today. \nI'm hoping to see much more from exosomes as a delivery modality; CTCL is\xe2\x80\xa6"""
2020-12-30,"b""Exciting early stage results from $CDAK today. \nI'm hoping to see much more from exosomes as a delivery modality; CTCL is cool but getting to the holy grail of BBB delivery will be a game changer.\n\nUsing the body's natural mechanisms is a tried and true winning method in delivery"""
2020-12-30,b'RT @MSollender: $CDAK Codiak Reports Positive Initial Phase 1 Results for exoIL-12\xe2\x84\xa2 Demonstrating Tolerability and Absence of Systemic IL-1\xe2\x80\xa6'
2020-12-30,b'$CDAK breakout https://t.co/0lieMUgDY5'
2020-12-30,"b""The problem with $OVID is that the CEO lacks credibility  and there's no governance. Comp committee is headed by the CEO of $CDAK who signed off on a huge cash and stock bonus for Levin AFTER the trial failure. Even priced his options at post failure strikes."""
2020-12-30,b'Rose Above Upper Bollinger Band today: $NBA $STKS $CDAK $BNFT $CFACU $FMAT ... https://t.co/AyIukUGmib'
2020-12-30,b'$CDAK stock gains 10.1%. View latest news. https://t.co/PHigyYOlYn'
2020-12-30,b'RT @MarcJacksonLA: $CDAK Codiak Reports Positive Initial Phase 1 Results for exoIL-12\xe2\x84\xa2 Demonstrating Tolerability and Absence of Systemic I\xe2\x80\xa6'
2020-12-30,"b'$CDAK #Codiak BioSciences, Inc. Turning It Up to 12: [...] https://t.co/S1tBolmkUr #equity #stocks https://t.co/X0t6yeYs69'"
2020-12-30,b'RT @Biotech2k1: $CDAK someone explain to me how an Exsome is not just LNP with a much cooler name? It is still just a phospholipid bilayer\xe2\x80\xa6'
2020-12-30,b'$CDAK Codiak Reports Positive Initial Phase 1 Results for exoIL-12\xe2\x84\xa2 Demonstrating Tolerability and Absence of Systemic IL-12 Exposure in Healthy Volunteers https://t.co/HXArmV8DQf'
2020-12-30,b'$CDAK someone explain to me how an Exsome is not just LNP with a much cooler name? It is still just a phospholipid bilayer with a few proteins embeded. Its just a endogenous LNP structure vs LNP being man made.'
2020-12-30,b'$OSMT -26.8% (receives letter from FDA for NDA for arbaclofen; FDA recommends co conduct a new study to show efficacy of arbaclofen) \n\n$CDAK -6.8% (Phase 1 exoIL-12 update)'
2020-12-30,"b'$CDAK: Codiak BioSciences announced that the primary objectives were met in the initial part of its Phase 1 trial,... https://t.co/N2Pi5DShLn'"
2020-12-30,"b'$CDAK / Codiak BioSciences files form 8-K - Financial Statements and Exhibits, Other Events -  8-K https://t.co/DYKtDDws4w'"
2020-12-30,"b'Filing for 8-K [Press/News Current Report] has been made with the SEC:  $CDAK Codiak BioSciences, Inc  https://t.co/GjcdaA0VLa'"
2020-12-30,b'$CDAK - Codiak posts positive initial phase 1 results for exoil-12 https://t.co/QWcFIm1yXq'
2020-12-30,b'RT @MSollender: $CDAK Codiak Reports Positive Initial Phase 1 Results for exoIL-12\xe2\x84\xa2 Demonstrating Tolerability and Absence of Systemic IL-1\xe2\x80\xa6'
2020-12-30,b'$CDAK Reveals findings from early-stage trial evaluating a single ascending dose of exoIL-12 in healthy volunteers       #CodiakBioSciences       https://t.co/jescJKK7f2'
2020-12-30,b'$CDAK Codiak Reports Positive Initial Phase 1 Results for exoIL-12\xe2\x84\xa2 Demonstrating Tolerability and Absence of Systemic IL-12 Exposure in Healthy Volunteers https://t.co/RJd483DeRQ'
2020-12-30,"b'Today we reported positive initial Ph1 results for our engineered #exosome therapeutic candidate exoIL-12, demonstrating tolerability and absence of systemic IL-12 exposure in healthy volunteers. $CDAK https://t.co/IQvOPDnUvT https://t.co/rlZ3sSdR1X'"
2020-12-30,b'Codiak reports initial Phase 1 results for exoIL-12\n$CDAK'
2020-12-30,b'$CDAK Codiak Reports Positive Initial Phase 1 Results for exoIL-12\xe2\x84\xa2 Demonstrating Tolerability and Absence of Systemic IL-12 Exposure in Healthy Volunteers\n\nhttps://t.co/nPZTiBZ5M3'
2020-12-30,b'$CDAK Codiak Reports Positive Initial Phase 1 Results for exoIL-12\xe2\x84\xa2 Demonstrating Tolerability and Absence of Systemic IL-12 Exposure in Healthy Volunteers\nhttps://t.co/Pjoz5rhXPI'
2020-12-29,b'Long $FREQ today.  $CDAK needs company'
2020-12-29,b'$RDGL VIVOS INC. DISRUPTIVE CANCER TREATMENT TECHNOLOGY PENDING FDA BREAKTHROUGH DEVICE DESIGNATION https://t.co/m1PPbL5Nzy $QURE $MESO $AVRO $OGEN $APVO $CORT $ADAP $APLS $ARAV $BPTH $CDAK $ENTX $NCNA  $RDHL $VBIV $BNTX $DTIL $EIGR $ATNM $MRNA https://t.co/PFwK7FGdak'
2020-12-28,b'RT @semodough: GS view $CDAK exosome technology as a best-in-class approach to a potential new class of therapeutic agents based on exosome\xe2\x80\xa6'
2020-12-27,b'RT @semodough: GS view $CDAK exosome technology as a best-in-class approach to a potential new class of therapeutic agents based on exosome\xe2\x80\xa6'
2020-12-27,b'RT @semodough: GS view $CDAK exosome technology as a best-in-class approach to a potential new class of therapeutic agents based on exosome\xe2\x80\xa6'
2020-12-27,"b'GS view $CDAK exosome technology as a best-in-class approach to a potential new class of therapeutic agents based on exosomes, which biopharma industry has had historical challenges in developing (re: manufacturing quality quantity). team at CDAK has finally overcome challenges'"
2021-01-07,"b'$PLUG $CDAK $FLUX alerted at $12, $13, $5 in terms of lesser known names. High of $46.95,$37.85, $19.86 today'"
2021-01-07,b'Hit &amp; Run Nightly Report long plays for Thursday Dec 7\n\n$NTLA\n$CDAK\n$AMBA\n$CREE'
2021-01-07,b'Today #StockMarket Top Gainer $DQWS $PLUG $BITW $GDLC $MTLS $CDAK $ARCT $CLSK $MAXN $BE $AI $CRSP $PACB $PLL $NTLA $SZOXF $CVAC $AMSC $MSTR $SITM #stocks #stock #stockstowatch #StocksToTrade #stocktrading #investing #Investment #invest #investor #investors https://t.co/5JE2nlrW3B https://t.co/kVPqFIIcie'
2021-01-07,"b'RT @Bernard22190947: Dr Strange Portfolio:\n$INFN-Latency \n$ONTO-semisweet\n$SQM-Lithium, Cachai?\n$TRQ-Copper for all those EVs\n$DNLI-Alzheim\xe2\x80\xa6'"
2021-01-07,"b'RT @Bernard22190947: Dr Strange Portfolio:\n$INFN-Latency \n$ONTO-semisweet\n$SQM-Lithium, Cachai?\n$TRQ-Copper for all those EVs\n$DNLI-Alzheim\xe2\x80\xa6'"
2021-01-07,b'@IncredibleTrade Wow ! UK Exosome play #RENE at an EV of just c.\xc2\xa340m vs $CDAK $660m'
2021-01-07,"b'RT @longwulf95: $CDAK Closed today above my price target at $35, 90% profit\nFollow me for free trade alerts.\n\n$OGEN $SNDL $SOS $GHSI $NAKD\xe2\x80\xa6'"
2021-01-07,"b'$CDAK Closed today above my price target at $35, 90% profit\nFollow me for free trade alerts.\n\n$OGEN $SNDL $SOS $GHSI $NAKD $FTFT $CBAT $CTRM $ZOM $PLUG $MARA $BNGO $CNET $FCEL $ISR $NIO $BBBY $NXTD $NCTY $JAGX $UVXY $DGLY \n\nhttps://t.co/zVV4d9W6wq\nSubscribe giveaway at 10k subs. https://t.co/vuVeMxwvqY https://t.co/DuM4WN3ikd'"
2021-01-07,b'@jfais20 #RENE and $CDAK in Exosomes'
2021-01-07,b'RT @Stockonomist: @JMHDeakin $CDAK Codiak is at $600m Market Cap just weeks after IPO so I would not rule anything out \n\nSome big manoeuvre\xe2\x80\xa6'
2021-01-07,b'RT @AimHardy: #RENE \n\nTotally agree $CDAK are around 18months further advanced in the development of Exosomes (delivery vehicle)\n\n#RENE Mca\xe2\x80\xa6'
2021-01-07,b'RT @AimHardy: #RENE \n\nTotally agree $CDAK are around 18months further advanced in the development of Exosomes (delivery vehicle)\n\n#RENE Mca\xe2\x80\xa6'
2021-01-07,b'RT @AimHardy: #RENE \n\nTotally agree $CDAK are around 18months further advanced in the development of Exosomes (delivery vehicle)\n\n#RENE Mca\xe2\x80\xa6'
2021-01-07,b'RT @AimHardy: #RENE \n\nTotally agree $CDAK are around 18months further advanced in the development of Exosomes (delivery vehicle)\n\n#RENE Mca\xe2\x80\xa6'
2021-01-07,b'RT @AimHardy: #RENE \n\nTotally agree $CDAK are around 18months further advanced in the development of Exosomes (delivery vehicle)\n\n#RENE Mca\xe2\x80\xa6'
2021-01-07,"b""#RENE \n\nTotally agree $CDAK are around 18months further advanced in the development of Exosomes (delivery vehicle)\n\n#RENE Mcap= \xc2\xa360m\n$CDAK MCap= $591m\n\n3 Companies evaluating RENE's platform\n\nCurrently snowed under with demand off other companies for Proof of Concept trials https://t.co/bBPx8uY9x8 https://t.co/jJ2ARgyB4O"""
2021-01-07,b'RT @Stockonomist: @JMHDeakin $CDAK Codiak is at $600m Market Cap just weeks after IPO so I would not rule anything out \n\nSome big manoeuvre\xe2\x80\xa6'
2021-01-07,b'RT @Stockonomist: @JMHDeakin $CDAK Codiak is at $600m Market Cap just weeks after IPO so I would not rule anything out \n\nSome big manoeuvre\xe2\x80\xa6'
2021-01-07,b'@JMHDeakin $CDAK Codiak is at $600m Market Cap just weeks after IPO so I would not rule anything out \n\nSome big manoeuvres being made in Exosomes space \n\n#RENE EV currently c. \xc2\xa330m ?'
2021-01-06,"b'$CDAK +10% back to highs, might see better day for $EX1.'"
2021-01-06,b'@JMHDeakin @cubeinvests Talking about major imminent Value Inflection points and size/scope of Value Realisation potential\n\nNote at 100p Mkt Cap = \xc2\xa357m\n\nDeals in Exosomes have included cash upfronts of $20-56m with total headline deal sizes amounting to $1000m+\n\n#RENE $CDAK https://t.co/7JhkEWgkZR'
